tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sanofi (SNY) Acquires Dynavax in $2.2 Billion Deal after FDA Rebuff
PremiumMarket NewsSanofi (SNY) Acquires Dynavax in $2.2 Billion Deal after FDA Rebuff
21h ago
Dynavax Technologies Reports Strong Q3 Earnings and Strategic Growth
Premium
Company Announcements
Dynavax Technologies Reports Strong Q3 Earnings and Strategic Growth
2M ago
Dynavax’s Promising Growth and Strategic Initiatives Justify Buy Rating with $25 Target
Premium
Ratings
Dynavax’s Promising Growth and Strategic Initiatives Justify Buy Rating with $25 Target
2M ago
Dynavax reports results from Phase 1/2 clinical trial of Z-1018
PremiumThe FlyDynavax reports results from Phase 1/2 clinical trial of Z-1018
2M ago
Dynavax Announces Management Restructuring Changes
Premium
Company Announcements
Dynavax Announces Management Restructuring Changes
2M ago
Buy Rating for Dynavax Driven by Promising Z-1018 Vaccine Developments and Heplisav Revenue Growth
Premium
Ratings
Buy Rating for Dynavax Driven by Promising Z-1018 Vaccine Developments and Heplisav Revenue Growth
4M ago
Dynavax’s Strong Q2 Performance and Strategic Growth Justify Buy Rating
PremiumRatingsDynavax’s Strong Q2 Performance and Strategic Growth Justify Buy Rating
5M ago
Dynavax Technologies Reports Strong Q2 2025 Results
Premium
Company Announcements
Dynavax Technologies Reports Strong Q2 2025 Results
5M ago
Dynavax: Strong Heplisav Sales and Promising Vaccine Pipeline Justify Buy Rating
Premium
Ratings
Dynavax: Strong Heplisav Sales and Promising Vaccine Pipeline Justify Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100